Across several dozen hospitals in the U.K., people with acute unexplained syncope were randomized to immediate 14-day cardiac ...

In patients with syncope who present to the emergency department for evaluation, diagnosing an underlying cardiac arrhythmia ...

Starting 14-day ECG monitoring immediately after ED assessment for unexplained syncope did not result in fewer ...

For patients with syncope, 14-day cardiac monitoring does not reduce the number of syncope episodes at one year, according to ...

Broadcaster Seo Jung-hee said she has experienced repeated fainting spells for about 50 years without knowing the cause. She ...

New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of ...

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President ...

USA: Researchers have found in a recent study that patients with mitral valve prolapse (MVP) undergoing cardiovascular ...

With fam-trastuzumab deruxtecan-nxki, a HER2-directed antibody drug conjugate (ADC), AstraZeneca and Daiichi Sankyo are aiming to improve outcomes in previously treated HER2-positive, HER2-low and ...

Bayer today announced the presentation of first detailed results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital, that evaluated the investigational ...

Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the supplemental New Drug Application ( sNDA) for nebulized Tyvaso ® ...